Early signs 'female viagra' is a flop

EARLY indications suggest flibanserin (Addyi) may be a flop, according to US sales of the drug described as the first female Viagra.

Only 1000 prescriptions have been filled in its first two months on the market, despite estimates that five to nine million US women have hypoactive sexual desire disorder, for which the drug is approved by the FDA.

The drug’s manufacturer, Sprout Pharmaceuticals, has blamed a lack of health insurance funding and tight restrictions for the slow uptake. Pharmacies and clinicians need special certification to supply

Latest

Trending